Interpretation
The cutoff values for serological evidence of Group A streptococcal disease vary dependent on the individual assay used by the laboratory and population based “Normals”. Rising antibody levels of paired serology (2-4 weeks if not initially raised) provides greater information than testing on a single presentation sample.
In the use and interpretation of Strep A antibody testing for ARF please refer to the Aotearoa New Zealand guidelines for the prevention , diagnosis, and management of Acute Rheumatic Fever and Rheumatic Heart Disease 2024 update, and the associated upper limits of normal for serum streptococcal antibody titres used in Aotearoa for acute rheumatic fever.
Interpretation in conjunction with Anti-Dnase B result should also be taken into account.
Reference Intervals
Results are reported as International Units per mL:
For reference ranges please refer to the Aotearoa New Zealand guidelines for the prevention, diagnosis, and management of Acute Rheumatic Fever and Rheumatic Heart Disease 2024 update.
https://static.info.content.health.nz/docs/health-pros/topics/diseases-conditions/rheumatic-fever/Aotearoa-New-Zealand-Guidelines-for-the-Prevention-Diagnosis-and-Management-of-Acute-Rheumatic-Fever-and-Rheumatic-Heart-Disease-Summary-Guide.pdf
The ASO antibody kit used in our laboratory is The Beckman Coulter OSR6194 Anti-streptolysin O assay.
The manufacturers Reference intervals are:
Adults ≤ 200 IU/mL
Children ≤ 150 IU/mL
*NOTE: Expected values may vary with age, sex, sample type, diet and geographical location. The transferability of the above Manufacturers ranges to our own unique geographical and population makeup may not apply. For diagnostic purposes, results should always be assessed in conjunction with the patient’s medical history, clinical examinations and other findings. Please refer to the NZ guidelines above.
Test Method
Beckman Latex Turbidimetric Assay